Stay updated with the latest stock market news and insights
Weekly insights + SMS alerts
United States Antimony Inc. (UAMY) had a rough Tuesday after the bell. The company posted its second-quarter results, and the numbers didn't exactly inspire confidence. Shares sank 14.44% to $5.63 in extended trading.
So what went wrong? Let's break it down.
The company reported quarterly earnings of zero cents per share, missing the analyst consensus estimate of one cent. Revenue came in at $7.925 million, well below the Street's expectation of $21.7 million and down from $10.53 million in the same period last year.
That's a tough quarter, no two ways about it. But management wants you to look past the headline numbers. Here are some of the operational highlights they pointed to:
CEO Gary C. Evans tried to put a positive spin on things, saying, "While our overall operations are continuing to improve markedly each month, those successes are only slowly trickling into our financial performance. While we made our first deliveries to the government during the second quarter, none of that achievement was reflected during this financial reporting period."
He also gave a hint of what's to come: "We currently anticipate the third quarter should see a minimum of $9-$10 million of additional sales, all to the U.S. Government."
But here's the kicker: U.S. Antimony slashed its fiscal 2026 revenue outlook in half. The company now expects revenue in a range of $60 million to $75 million, versus the $114.04 million estimate. That's a big haircut, and it's likely why investors are hitting the sell button.
So, is this a buying opportunity or a warning sign? The government contracts could be a game-changer, but the market seems skeptical right now. As always, do your own research and decide what makes sense for your portfolio.
Real-time alerts on price moves, news, and trading opportunities.
Join 20,000+ investors. No spam, ever.
